Rutgers Cancer Institute of New Jersey: First Patient Recently Treated With New Non-Surgical Therapy for Urothelial Cancer at Rutgers Cancer Institute
January 29, 2021
January 29, 2021
NEW BRUNSWICK, New Jersey, Jan. 29 -- Rutgers Cancer Institute of New Jersey issued the following news:
Rutgers Cancer Institute of New Jersey, the state's only National Cancer Institute-designated Comprehensive Cancer Center, has treated its first upper tract urothelial cancer patient with a recently approved therapy option known as mitomycin gel, which is the first non-surgical treatment for this type of disease.
Saum Ghodoussipour, MD, urologic oncologist and directo . . .
Rutgers Cancer Institute of New Jersey, the state's only National Cancer Institute-designated Comprehensive Cancer Center, has treated its first upper tract urothelial cancer patient with a recently approved therapy option known as mitomycin gel, which is the first non-surgical treatment for this type of disease.
Saum Ghodoussipour, MD, urologic oncologist and directo . . .